Showing results (321-330 of 1,138) with videos related to
Sort By:
Pageof 114
Drugs - Real World Outcomes|July 20, 2022
Associations of Cardiovascular Agents and Metformin with Depression Symptoms: A Cross-Sectional Analysis from the HUNT Study, NorwayIvana Bojanić, Ottar Bjerkeset, Lana J Williams, et al.Australian Health Review : a Publication of the Australian Hospital Association|November 27, 2010
A qualitative evaluation of a regional Early Psychosis Service 3 years after its commencementThomas Callaly, Carmel A Ackerly, Mary E Hyland, et al.Acta Neuropsychiatrica|March 9, 2016
The validity and internal structure of the Bipolar Depression Rating Scale: data from a clinical trial of N-acetylcysteine as adjunctive therapy in bipolar disorderMichael Berk, Seetal Dodd, Olivia M Dean, et al.Journal of Neuroengineering and Rehabilitation|February 15, 2018
An investigation into closed-loop treatment of neurological disorders based on sensing mitochondrial dysfunctionScott D Adams, Abbas Z Kouzani, Susannah J Tye, et al.Translational Psychiatry|March 7, 2018
Differential effect of quetiapine and lithium on functional connectivity of the striatum in first episode maniaOrwa Dandash, Murat Yücel, Rothanthi Daglas, et al.Bipolar Disorders|May 16, 2006
Symptomatic and functional outcome 12 months after a first episode of psychotic mania: barriers to recovery in a catchment area samplePhilippe Conus, Sue Cotton, Amal Abdel-Baki, et al.Current Pharmaceutical Design|September 17, 2016
The Role of Microbiota and Intestinal Permeability in the Pathophysiology of Autoimmune and Neuroimmune Processes with an Emphasis on Inflammatory Bowel Disease Type 1 Diabetes and Chronic Fatigue SyndromeGerwyn Morris, Michael Berk, André F Carvalho, et al.Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|January 15, 2009
Serum levels of brain-derived neurotrophic factor and thiobarbituric acid reactive substances in chronically medicated schizophrenic patients: a positive correlationClarissa Severino Gama, Michael Berk, Ana Cristina Andreazza, et al.Human Psychopharmacology|December 7, 2011
Who's left? Symptoms of schizophrenia that predict clinical trial dropoutJason Thompson, Michael Berk, Olivia Dean, et al.Metabolic Brain Disease|September 4, 2013
N-Acetyl cysteine reverses social isolation rearing induced changes in cortico-striatal monoamines in ratsMarisa Möller, Jan L Du Preez, Francois P Viljoen, et al.Pageof 114